在肝硬化中选择性跨关节内肝移植系统静脉突变的创造改善了身体组成和功能:试点随机试验
Takeshi Suzuki1, Kentaro Yamada1, Arianna Anoushiravani1
1Dotter Department of Interventional Radiology, Oregon Health and Science University, 3181 S.W. Sam Jackson Park Road, Portland, OR, 97239, USA.
Cardiovascular and interventional radiology
|March 10, 2026
概括
跨内肝移植系统分流 (TIPS) 创建改善了肝硬化患者的肌肉质量和身体功能. 这项试点研究表明,TIPS可能是这种人群中麻症和脆弱性的可行治疗方法.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 胃肠病学 胃肠病学
- 临床营养学 临床营养学
背景情况:
- 肉症和脆弱性显著增加了肝硬化患者的发病率和死亡率.
- 跨内肝移植系统分流 (TIPS) 创建用于耐火性炎,但其对肌肉损失的影响需要进一步调查.
- 关于TIPS及其对肉病和肝硬化的脆弱性影响的前性证据有限.
研究的目的:
- 评估TIPS创建对肝硬化患者身体组成和身体功能的影响.
- 评估TIPS是否可以逆转肌肉损失并改善肝硬化患者的脆弱性.
- 为了比较接受标准护理 (SOC) 和接受SOC + TIPS的患者之间的结果.
主要方法:
- 一个单一中心的试点随机对照试验,涉及26名患有肝硬化症的成年人,患有门高血压并发症.
- 参与者被随机分配到标准护理 (SOC) 或SOC + TIPS创建.
- 主要结局包括CT衍生骨肌指数 (SMI),psoas肌指数 (PMI),肥胖,短物理性能电池和肝脏脆弱指数,在基线和6个月评估.
主要成果:
- 在TIPS集团中,SMI和PMI显著增加,脂肪指数也有所改善.
- 相比之下,标准护理组在身体组成指标上没有显著变化.
- 与SOC组相比,TIPS队列在功能评分中表现出显著的改善,不增加不良事件,肝脑病,MELD评分或生存率.
结论:
- 创建TIPS有望改善肝硬化患者的身体组成,身体功能和生活质量.
- 这些发现表明,TIPS可能是对这种人群中肉症和脆弱性的有益干预.
- 需要进行更大规模的随机试验来证实这些初步发现,并确定TIPS在治疗肉症和肝硬化中的脆弱性方面的作用.
相关概念视频
Hepatic Portal System
8.2K
The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
8.2K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
274
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
274
Cirrhosis I: Introduction
30
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
30
Cirrhosis II: Pathophysiology
49
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to...
49
Portal Hypertension
57
Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...
57
Hepatic Encephalopathy
71
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic...
71


